Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998)
about
Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid DehydrogenasesA reliable computational workflow for the selection of optimal screening librariesIn depth analysis on the binding sites of adamantane derivatives in HCV (hepatitis C virus) p7 channel based on the NMR structurePharmacophore modeling for anti-Chagas drug design using the fragment molecular orbital method.Software and resources for computational medicinal chemistryStructure-based discovery of potentially active semiochemicals for Cydia pomonella (L.).A Biologically Active Analog of the Sex Pheromone of the Emerald Ash Borer, Agrilus planipennis.Discovery of new [Formula: see text] proteasome inhibitors using a knowledge-based computational screening approach.Pharmacophore Alignment Search Tool (PhAST): Significance Assessment of Chemical Similarity.Pharmacophore Model Refinement for 11β-Hydroxysteroid Dehydrogenase Inhibitors: Search for Modulators of Intracellular Glucocorticoid Concentrations.In Silico Predictions of Drug - Drug Interactions Caused by CYP1A2, 2C9 and 3A4 Inhibition - a Comparative Study of Virtual Screening Performance.Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development.Plant alkaloids that cause developmental defects through the disruption of cholinergic neurotransmission.Modeling conformational transitions in kinases by molecular dynamics simulations: achievements, difficulties, and open challengesNatural products as leads in schistosome drug discovery.In silico prediction of hERG inhibition.Synthesis and preliminary in vitro biological evaluation of 5-chloro-2-(substituted phenyl)benzo[d]thiazole derivatives designed as novel antimelanogenesis agents.Activity and property landscape modeling is at the interface of chemoinformatics and medicinal chemistry.Chalcone Derivatives: Promising Starting Points for Drug Design.Pharmacophore modeling for COX-1 and -2 inhibitors with LigandScout in comparison to Discovery Studio.Molecular insight on the binding of NNRTI to K103N mutated HIV-1 RT: molecular dynamics simulations and dynamic pharmacophore analysis.Structure-Based Pharmacophores for Virtual Screening.Relationships between molecular structure and perceived odor quality of ligands for a human olfactory receptor.An Integrative Drug Repurposing Pipeline: Switching Viral Drugs to Breast Cancer.GeauxDock: A novel approach for mixed-resolution ligand docking using a descriptor-based force field.A combinatorial approach for the discovery of cytochrome P450 2D6 inhibitors from nature.Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation.Mechanistic studies for tri-targeted inhibition of enzymes involved in cholesterol biosynthesis by green tea polyphenols.Combined pharmacophore and 3D-QSAR study on a series of Staphylococcus aureus Sortase A inhibitors.Construction and assessment of reaction models of class I EPSP synthase: molecular docking and density functional theoretical calculations.Machine learning-, rule- and pharmacophore-based classification on the inhibition of P-glycoprotein and NorA.Directing evolution: the next revolution in drug discovery?Discriminating Agonist from Antagonist Ligands of the Nuclear Receptors Using Different Chemoinformatics Approaches.Exploring the structural requirements in multiple chemical scaffolds for the selective inhibition of Plasmodium falciparum calcium-dependent protein kinase-1 (PfCDPK-1) by 3D-pharmacophore modelling, and docking studies.New QSAR prediction models derived from GPCR CB2-antagonistic triaryl bis-sulfone analogues by a combined molecular morphological and pharmacophoric approach.Anti-inflammatory effect of (E)-4-(3,7-dimethylocta-2,6-dienylamino)phenol, a new derivative of 4-nerolidylcatechol2D, 3D-QSAR, and pharmacophore studies on thiazolidine-4-carboxylic acid derivatives as neuraminidase inhibitors in H3N2 influenza virusQSAR and Molecular Modeling Approaches for Prediction of Drug MetabolismProgress in the Understanding of the Key Pharmacophoric Features of the Antimalarial Drug Dihydroartemisinin: An Experimental and Theoretical Charge Density Study
P2860
Q26772046-03A8A5B0-E52E-49F1-9276-9CBB8BDC0191Q27902327-B2F53437-44A7-43C5-BAF7-A7878226C447Q28542096-230D6CBB-9356-41FC-9BBF-3CDD23FD5444Q28547166-087A2E92-688E-4B73-A147-F2E62FAF07BFQ28728561-426A1AD1-FE82-4D5F-BF68-7E0FCD17FB83Q34542053-050A088B-6CF1-4D6B-9FB8-BE0CB50C1D70Q35580777-D9D4AD30-2C8A-4D1F-A00F-8B1CC599985FQ35732424-1D09C92D-0766-41A4-B127-8D4220A491D8Q36092217-3EBDAA06-5A3F-4706-86E0-7EFD3C75C9A9Q36093176-81699168-6F30-4A54-9562-6058A152C5F2Q36094897-DF4A734E-ECF1-4AD8-9515-01CF9E78C943Q37894718-3EF62A8F-44CC-4659-8567-555EB800309FQ38171428-0CB4E110-40FD-4CF4-ACC0-5484491337F5Q38214683-BE6E5A29-311D-43E6-BE19-98DABDF5671AQ38334179-0CED3ABA-92EB-4DD4-B7C5-6EECA4C63D71Q38447279-D449D281-6915-4E78-9DEF-14B33DDE2A52Q38458527-F308424F-8B76-4570-AF6F-C57F63FDD999Q38541498-AB3C5E8A-16D2-45F2-BB79-D5635DC4D9DCQ39027317-4A31C7C1-2776-45F7-B9C2-17A3316F49E5Q39077950-06CB5728-D5C2-4BAA-97C3-0831305AB347Q39306655-F889D3F3-818D-45C9-8469-745609D723C3Q39750808-F6AD25C6-6663-430B-8B33-083896A32832Q39964651-58F760CD-06F4-499F-BA26-31B757DD080CQ40469984-03CFC118-0781-465C-812A-2FB4E9651280Q40650150-C8AEC2C4-9139-43D2-802D-FE425A5B8667Q41388739-7359C6C8-7C48-4ADE-857D-1B309D7FD961Q41812639-09E40B3A-A5D5-4DC2-A040-7813C34164DCQ42215725-6F78C2F7-1A34-4779-8500-AE157A989C07Q44307807-E4EE907E-0E2B-405C-A4CA-EE0CE951A42DQ45937125-F54E7D5E-DA54-4CB7-809B-AB7D3599D38AQ45950000-D317E8E1-EB39-4895-A836-18B9D0612F98Q47764181-F76E9F47-71F9-43C4-8317-361078904F60Q48185940-6665675D-54BC-444B-936E-B2CDA395B980Q48350406-0638DDBB-7D93-4767-B938-092753676087Q51552963-73DFE69B-645B-4197-B65F-1C22A7E20E00Q56514535-F4E47CB4-B624-4B17-87BB-201A83C60617Q56797626-2E9C902E-1C2E-4657-978A-1FA223BCAA15Q57019425-868519F5-D3FF-4FEC-9B68-FE6834256213Q58857835-0501E492-E6EA-41CC-915E-219E1E32CDB8
P2860
Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998)
description
article
@en
im Januar 1998 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 1998
@uk
ലേഖനം
@ml
name
Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998)
@en
Glossary of terms used in medicinal chemistry
@nl
type
label
Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998)
@en
Glossary of terms used in medicinal chemistry
@nl
prefLabel
Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998)
@en
Glossary of terms used in medicinal chemistry
@nl
P2093
P356
P1476
Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998)
@en
P2093
C. G. Wermuth
C. R. Ganellin
L. A. Mitscher
P. Lindberg
P304
P356
10.1351/PAC199870051129
P577
1998-01-01T00:00:00Z